FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173156911> ?p ?o ?g. }

• W3173156911 endingPage "133" @default.
• W3173156911 startingPage "123" @default.
• W3173156911 abstract "Low back pain is a leading cause of disabilities worldwide, and intervertebral disc degeneration (IVDD)-related disorders have been recognised as one of the main contributors. Nevertheless, the underlying mechanism has not yet been fully understood. The aim of this study was to investigate the role of the miR-133a-5p/FBXO6 axis in the regulation of IVDD.RT-qPCR, WB and IHC were performed to assess the expression of FBXO6 in human IVD tissues. Nucleus pulposus (NP) cells were treated with IL-1β to induce IVDD cellular model. Silence of FBXO6 was achieved using specific siRNAs. CCK-8 assay, flow cytometry, TUNEL assay, RT-qPCR and WB were used to evaluate the role and mechanism of FBXO6 in the process of IVDD. Online tools, GSE datasets and RT-qPCR were used to search the candidate miRNAs targeting FBXO6. The direct binding sites between FBXO6 and miR-133a-5p were further verified by a dual luciferase assay. RT-qPCR, WB and rescue experiments were conducted to identify the regulatory function of miR-133a-5p on the expression of aggrecan, collagen Ⅱ, MMP3, ADAMTS5, IL-6 and COX2. In addition, the role of the NF-κB pathway in regulating miR-133a-5p was studied using lentiviral shRNA, WB and RT-qPCR.Results showed that FBXO6 mainly expressed in the NP tissue of IVD and the expression of FBXO6 decreased with the process of IVDD as well as under IL-1β stimulation. The silence of FBXO6 led to the decreased expression of aggrecan and collagen Ⅱ and the increased expression of MMP3, ADAMTS5, IL-6 and COX2, which further induced the degeneration of NP cells. The bioinformatic analysis showed that miR-133a-5p was the candidate miRNA targeting FBXO6. miR-133a-5p was upregulated in IVDD tissues and significantly inhibited the expression of FBXO6. The inhibition of miR-133a-5p ameliorated the acceleration of IVDD induced by the silence of FBXO6 in vitro. Moreover, it was demonstrated that IL-1β regulated the expression of the miR-133a-5p/FBXO6 axis via the NF-κB pathway in NP cells.miR-133a-5p was upregulated by IL-1β to aggravate intervertebral disc degeneration via sponging FBXO6. Inhibiting miR-133a-5p expression or rescuing FBXO6 expression may be promising strategies for the treatment of IVDD.This study suggests that the miR-133a-5p/FBXO6 axis could regulate NP cells proliferation, apoptosis, synthesis and degradation of extracellular matrix, which provides a promising therapeutic target and strategy for the treatment of IVDD." @default.
• W3173156911 created "2021-07-05" @default.
• W3173156911 creator A5003037880 @default.
• W3173156911 creator A5005401964 @default.
• W3173156911 creator A5008665957 @default.
• W3173156911 creator A5019460834 @default.
• W3173156911 creator A5041837665 @default.
• W3173156911 creator A5042243015 @default.
• W3173156911 creator A5043619069 @default.
• W3173156911 creator A5049632970 @default.
• W3173156911 creator A5051744476 @default.
• W3173156911 creator A5053725057 @default.
• W3173156911 creator A5069233763 @default.
• W3173156911 date "2021-07-01" @default.
• W3173156911 modified "2023-10-17" @default.
• W3173156911 title "Role of the miR-133a-5p/FBXO6 axis in the regulation of intervertebral disc degeneration" @default.
• W3173156911 cites W144423133 @default.
• W3173156911 cites W1966188170 @default.
• W3173156911 cites W1991533918 @default.
• W3173156911 cites W2004065133 @default.
• W3173156911 cites W2025246434 @default.
• W3173156911 cites W2046467581 @default.
• W3173156911 cites W2057421194 @default.
• W3173156911 cites W2067435335 @default.
• W3173156911 cites W2083640838 @default.
• W3173156911 cites W2092798278 @default.
• W3173156911 cites W2098082628 @default.
• W3173156911 cites W2104082092 @default.
• W3173156911 cites W2129746561 @default.
• W3173156911 cites W2135492990 @default.
• W3173156911 cites W2139030085 @default.
• W3173156911 cites W2149650813 @default.
• W3173156911 cites W2189695522 @default.
• W3173156911 cites W2323209002 @default.
• W3173156911 cites W2552164591 @default.
• W3173156911 cites W2741605333 @default.
• W3173156911 cites W2751884637 @default.
• W3173156911 cites W2790989829 @default.
• W3173156911 cites W2884212875 @default.
• W3173156911 cites W2886684148 @default.
• W3173156911 cites W2888749522 @default.
• W3173156911 cites W2891478978 @default.
• W3173156911 cites W2901270382 @default.
• W3173156911 cites W2913699457 @default.
• W3173156911 cites W2920464441 @default.
• W3173156911 cites W2932485067 @default.
• W3173156911 cites W2941707390 @default.
• W3173156911 cites W2946141250 @default.
• W3173156911 cites W2959464685 @default.
• W3173156911 cites W2963715560 @default.
• W3173156911 cites W2972746271 @default.
• W3173156911 cites W3008505557 @default.
• W3173156911 cites W3024944464 @default.
• W3173156911 cites W3046858611 @default.
• W3173156911 cites W3080193067 @default.
• W3173156911 cites W3093979170 @default.
• W3173156911 cites W3094804898 @default.
• W3173156911 cites W3125740254 @default.
• W3173156911 doi "https://doi.org/10.1016/j.jot.2021.05.004" @default.
• W3173156911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8233105" @default.
• W3173156911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34249610" @default.
• W3173156911 hasPublicationYear "2021" @default.
• W3173156911 type Work @default.
• W3173156911 sameAs 3173156911 @default.
• W3173156911 citedByCount "10" @default.
• W3173156911 countsByYear W31731569112022 @default.
• W3173156911 countsByYear W31731569112023 @default.
• W3173156911 crossrefType "journal-article" @default.
• W3173156911 hasAuthorship W3173156911A5003037880 @default.
• W3173156911 hasAuthorship W3173156911A5005401964 @default.
• W3173156911 hasAuthorship W3173156911A5008665957 @default.
• W3173156911 hasAuthorship W3173156911A5019460834 @default.
• W3173156911 hasAuthorship W3173156911A5041837665 @default.
• W3173156911 hasAuthorship W3173156911A5042243015 @default.
• W3173156911 hasAuthorship W3173156911A5043619069 @default.
• W3173156911 hasAuthorship W3173156911A5049632970 @default.
• W3173156911 hasAuthorship W3173156911A5051744476 @default.
• W3173156911 hasAuthorship W3173156911A5053725057 @default.
• W3173156911 hasAuthorship W3173156911A5069233763 @default.
• W3173156911 hasBestOaLocation W31731569111 @default.
• W3173156911 hasConcept C104317684 @default.
• W3173156911 hasConcept C105702510 @default.
• W3173156911 hasConcept C142724271 @default.
• W3173156911 hasConcept C145059251 @default.
• W3173156911 hasConcept C196795494 @default.
• W3173156911 hasConcept C197534660 @default.
• W3173156911 hasConcept C204232928 @default.
• W3173156911 hasConcept C204787440 @default.
• W3173156911 hasConcept C2776164576 @default.
• W3173156911 hasConcept C2777755357 @default.
• W3173156911 hasConcept C3020332539 @default.
• W3173156911 hasConcept C48023723 @default.
• W3173156911 hasConcept C54355233 @default.
• W3173156911 hasConcept C60644358 @default.
• W3173156911 hasConcept C71924100 @default.
• W3173156911 hasConcept C86803240 @default.
• W3173156911 hasConcept C95444343 @default.
• W3173156911 hasConceptScore W3173156911C104317684 @default.

• next